December 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Western Asset Management Company (LAOIX, WATFX, WACPX) mutual fund. Investors who purchased mutual funds are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Western Asset Management… read more
December 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. (“Avid”) (NASDAQ: CDMO) and GHO Capital Partners and Ampersand Capital Partners. Investors who purchased Avid and continue to hold to the present are encouraged to obtain additional information and assist the investigation…. read more
December 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Steel Connect, Inc. (“Steel Connect”) (NASDAQ: STCN) and Steel Partners Holdings L.P. (“Steel Partners”). Investors who purchased Steel Connect and continue to hold to the present are encouraged to obtain additional information and assist the… read more
November 25, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Macy’s, Inc. (“Macy’s” or “the Company”) (NYSE: M). Investors who purchased Macy’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Macy’s has violated federal… read more
November 25, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Macy’s, Inc. (“Macy’s” or “the Company”) (NYSE: M). Investors who purchased Macy’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Macy’s has violated federal… read more
November 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation (“Quanterix” or “the Company”) (NASDAQ: QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Quanterix has violated federal… read more
November 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of e.l.f. Beauty, Inc. (“e.l.f. Beauty” or “the Company”) (NYSE: ELF). Investors who purchased e.l.f. Beauty securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether e.l.f…. read more
November 21, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Oklo Inc. (“Oklo” or “the Company”) (NYSE: OKLO). Investors who purchased Oklo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Oklo has violated federal… read more
November 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Target Corp. (“Target” or “the Company”) (NASDAQ: TGT). Investors who purchased Target securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Target has violated federal… read more
November 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. (“Arvinas” or “the Company”) (NASDAQ: ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arvinas has violated federal… read more
November 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spyre Therapeutics, Inc. (“Spyre” or “the Company”) (NASDAQ: SYRE). Investors who purchased Spyre securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Spyre has violated… read more
November 13, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. (“Neurogene” or “the Company”) (NASDAQ: NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Neurogene has violated federal… read more
November 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celanese Corporation (“Celanese” or “the Company”) (NYSE: CE). Investors who purchased Celanese securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Celanese has violated federal… read more
November 5, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. (“Extreme Networks” or “the Company”) (NASDAQ: EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to… read more
November 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (“Myriad” or “the Company”) (NASDAQ: MYGN). Investors who purchased Myriad securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Myriad has violated… read more
November 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ESSA Pharma Inc. (“ESSA” or “the Company”) (NASDAQ: EPIX). Investors who purchased ESSA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ESSA has violated… read more
November 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or “the Company”) (NYSE: HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
November 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Chipotle Mexican Grill, Inc. (“Chipotle” or “the Company”) (NYSE: CMG). Investors who purchased Chipotle securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Chipotle has… read more
October 31, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DZS, Inc. (“DZS” or “the Company”) (NASDAQ: DZSI). Investors who purchased DZS securities prior to March 10, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
October 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Janus International Group, Inc. (“Janus” or “the Company”) (NYSE: JBI). Investors who purchased Janus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Janus has… read more
October 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alto Neuroscience, Inc. (“Alto Neuroscience” or “the Company”) (NYSE: ANRO). Investors who purchased Alto Neuroscience securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alto… read more
October 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unisys Corporation (“Unisys” or “the Company”) (NYSE: UIS). Investors who purchased Unisys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Unisys has violated federal… read more
October 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CSX Corporation (“CSX” or “the Company”) (NASDAQ: CSX). Investors who purchased CSX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CSX has violated federal… read more
October 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN). Investors who purchased Stride securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Stride has violated federal… read more
October 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or “the Company”) (NASDAQ: NVAX). Investors who purchased Novavax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Novavax has violated federal… read more
October 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Biodexa Pharmaceuticals Plc (“Biodexa” or “the Company”) (NASDAQ: BDRX). Investors who purchased Biodexa securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Biodexa has violated… read more
October 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ: STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Shattuck has violated… read more
October 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc (“ADMA Biologics” or “the Company”) (NASDAQ: ADMA). Investors who purchased ADMA Biologics securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ADMA… read more
October 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Solar, Inc. (“First Solar” or “the Company”) (NASDAQ: FSLR). Investors who purchased First Solar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether First… read more
October 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JFrog Ltd. (“JFrog” or “the Company”) (NASDAQ: FROG). Investors who purchased JFrog securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JFrog has violated federal… read more